Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer (mCRPC): Results from an expanded access program.
David Thomson
No relevant relationships to disclose
Natalie Charnley
No relevant relationships to disclose
Omi Parikh
No relevant relationships to disclose